LOS ANGELES CAPITAL MANAGEMENT LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,020,315
-13.9%
87,281
-1.1%
0.00%
-20.0%
Q2 2023$1,185,704
-35.1%
88,222
-19.9%
0.01%
-37.5%
Q1 2023$1,826,668
-23.1%
110,173
-13.7%
0.01%
-33.3%
Q4 2022$2,374,011
+30.7%
127,635
-9.8%
0.01%
+33.3%
Q3 2022$1,816,000
-29.5%
141,542
-61.5%
0.01%
-30.8%
Q2 2022$2,577,000
+31.5%
367,634
+55.5%
0.01%
+62.5%
Q1 2022$1,960,000
+0.9%
236,475
-17.6%
0.01%
+14.3%
Q4 2021$1,942,000
+58.7%
286,845
+24.2%
0.01%
+16.7%
Q3 2021$1,224,000
+22.5%
230,965
+32.9%
0.01%
+50.0%
Q2 2021$999,000
-17.4%
173,785
-52.0%
0.00%
-20.0%
Q4 2020$1,209,000
+4.8%
362,065
-6.8%
0.01%0.0%
Q3 2020$1,154,000
-47.4%
388,385
-18.2%
0.01%
-54.5%
Q2 2020$2,194,000
+80.9%
474,870
+50.7%
0.01%
+37.5%
Q1 2020$1,213,000
+203.2%
315,005
+195.6%
0.01%
+300.0%
Q4 2019$400,000
-27.0%
106,560
+3.2%
0.00%
-33.3%
Q3 2019$548,000
+50.1%
103,210
+8.7%
0.00%
+50.0%
Q2 2019$365,000
+67.4%
94,960
+122.4%
0.00%
+100.0%
Q1 2019$218,000
+165.9%
42,7000.0%0.00%0.0%
Q4 2018$82,000
-49.4%
42,700
-0.5%
0.00%0.0%
Q3 2018$162,000
+205.7%
42,900
+152.9%
0.00%
Q2 2018$53,00016,9600.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 252,199$749,0002.35%
MANGROVE PARTNERS IM, LLC 3,031,965$9,005,0001.14%
ARMISTICE CAPITAL, LLC 10,000,000$29,700,0001.08%
GABLES CAPITAL MANAGEMENT INC. 432,864$1,286,0000.83%
Worth Venture Partners, LLC 268,682$798,0000.66%
XTX MARKETS LLC 18,749$56,0000.27%
Capital Impact Advisors, LLC 203,133$603,0000.18%
Wealthspire Advisors, LLC 337,770$1,003,0000.06%
ROYCE & ASSOCIATES LP 1,784,890$5,301,0000.06%
XML Financial, LLC 40,000$119,0000.04%
View complete list of CATALYST PHARMACEUTICALS INC shareholders